#274 Making your head spin: Betahistine for benign paroxysmal positional vertigo
CLINICAL QUESTION
Is betahistine effective for adults with benign paroxysmal positional vertigo (BPPV)?
BOTTOM LINE
When used alone without repositioning maneuvers (i.e. Epley maneuver), limited data suggest more patients have “improved” dizziness with betahistine compared to placebo (75% versus 52% placebo at 3 months). However, betahistine is less effective than Epley. Whether betahistine is effective for residual dizziness post-Epley is uncertain. At best, 44% of patients compared to 21% on placebo will “improve”.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
All randomized, controlled trials (RCTs). Differences statistically significant unless stated.
- Betahistine without Epley maneuver:1
- Industry-sponsored, double-blind RCT, 63 patients, betahistine 16mg BID or placebo. After 3 months treatment:
- Number of patients “improved” (not defined) on vertigo scale: 75% betahistine, 52% placebo.
- Headache: 18% (betahistine) versus 3%, not statistically different.
- Number of patients “improved” (not defined) on vertigo scale: 75% betahistine, 52% placebo.
- Industry-sponsored, double-blind RCT, 63 patients, betahistine 16mg BID or placebo. After 3 months treatment:
- Betahistine compared to Epley maneuver:
- 90 patients, betahistine, betahistine plus Epley maneuver, or Epley maneuver (frequencies not stated).2 Baseline vertigo ~7.7 on 11-point scale (lower=better).
- After 1 week:
- Epley or combination better on vertigo scale: ~2.3 versus ~3.7 (betahistine).
- Difference likely clinically relevant.
- Epley or combination better on vertigo scale: ~2.3 versus ~3.7 (betahistine).
- After 1 week:
- 96 patients, betahistine 24mg BID or Epley maneuver (performed twice at baseline, repeated after 1 week if needed).3 Baseline dizziness disability ~75 on 100-point scale (lower=better).
- Disability score after 8 weeks treatment: 20 versus 10 (Epley), significance not reported.
- 90 patients, betahistine, betahistine plus Epley maneuver, or Epley maneuver (frequencies not stated).2 Baseline vertigo ~7.7 on 11-point scale (lower=better).
- Post-Epley maneuver:
- 100 patients with dizziness post-Epley maneuver, randomized to betahistine 24mg BID or no drug.4 After 5 days:
- No difference in any outcome.
- 78 patients (59 with dizziness post-Epley given up to 4 times/session), randomized (double-blind) to betahistine 16mg TID or placebo.5 After 1 week:
- No difference dizziness disability scores.
- Patients with “improved” dizziness (not defined): 59% versus 27% (placebo).
- Limitations: if used all randomized patients, improvement changes to 44% and 21%, respectively.
- 72 patients, double-blind, randomized to Epley, Epley plus placebo, or Epley plus betahistine 24mg bid.6 After 1 week:
- Adding betahistine did not significantly change dizziness disability score, vertigo score or number with “persistent symptoms”.
- 100 patients with dizziness post-Epley maneuver, randomized to betahistine 24mg BID or no drug.4 After 5 days:
- Betahistine adverse effects (mainly gastrointestinal and headache) poorly reported; often similar to placebo.7
- Betahistine (16mg) costs ~$25 for 90 tablets.8
Latest Tools for Practice
#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy
How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
some benefit to Betahistine in vertigo